Clinical Trials Logo

Ureter Calculi clinical trials

View clinical trials related to Ureter Calculi.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06158620 Not yet recruiting - Post Operative Pain Clinical Trials

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

Start date: May 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

Objective: To improve quality-of-life and health care delivery to patients receiving ureteral stents. Specific Aims: Evaluate the feasibility, practicality, and qualitative outcomes of utilizing intra-nasal ketorolac in patients with indwelling ureteral stents (Phase I), followed by a randomized trial comparing two non-steroidal anti-inflammatory drugs, intra-nasal Ketorolac versus oral Diclofenac. Hypotheses: Due to its favorable pharmacokinetics in relieving acute pain, investigators expect improved pain scores and a lower rate of unplanned clinical encounters in patients receiving intra-nasal ketorolac compared to those taking oral diclofenac following ureteroscopic surgery for urolithiasis. Study Rationale: Following ureteroscopic management of urolithiasis, patient with indwelling ureter stents have higher levels of discomfort compared to those without a ureter stent. Prior studies showed that intramuscular Ketorolac at time of ureter stent removal decreased the incidence of unplanned clinical encounters. Furthermore, onset of analgesic effect by intra-nasal ketorolac is faster than its oral form, and similar its intramuscular and intravenous counterparts.

NCT ID: NCT02011737 Not yet recruiting - Kidney Calculi Clinical Trials

Naftopidil 75mg for Improving Clearance of Urinary Stones

Start date: February 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate Efficacy and Safety of oral intake of Naftopidil 75mg once daily for the improving clearance of ureteral or renal stones.